Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Phreesia (PHR) EPS (Weighted Average and Diluted) (2020 - 2026)

Phreesia recorded quarterly EPS (Weighted Average and Diluted) of $0.02 in Q1 2026, down 71.43% quarter-over-quarter from $0.07 in Q4 2025, and up 118.18% year-over-year from $0.01 in Q1 2025.

Phreesia's EPS (Weighted Average and Diluted) history runs 7 years deep, the most recent figure standing at $0.02 for Q1 2026.

  • In Q1 2026, EPS (Weighted Average and Diluted) rose 118.18% year-over-year to $0.02; the TTM figure through Jan 2026 stood at $0.03 (up 102.94% YoY), while the FY2026 annual figure was $0.04, up 103.92% from the prior year.
  • EPS (Weighted Average and Diluted) came in at $0.02 for Q1 2026 at Phreesia, down from $0.07 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.07 in Q4 2025 to a low of -$0.99 in Q2 2022.
  • A 5-year average of -$0.46 and a median of -$0.55 in 2024 frame the typical range for EPS (Weighted Average and Diluted).
  • Across the five-year window, EPS (Weighted Average and Diluted) tumbled 416.67% in 2022 and soared 128.0% in 2025, its largest moves.
  • Phreesia's EPS (Weighted Average and Diluted) stood at -$0.76 in 2022, then climbed by 23.68% to -$0.58 in 2023, then jumped by 56.9% to -$0.25 in 2024, then jumped by 128.0% to $0.07 in 2025, then plunged by 71.43% to $0.02 in 2026.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods registered $0.02, $0.07, and $0.01 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn 1.48
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 0.67
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 0.82
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn 0.41
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn 0.10
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 0.22
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn -0.10
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn 0.02
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 0.25
10 Phreesia 632.62 Mn 558.79 Mn 113.28 Mn 0.05

Historic Data

Download Data 🔒
DateValue
Apr 30, 2026 0.05
Jan 31, 2026 0.02
Oct 31, 2025 0.07
Jul 31, 2025 0.01
Apr 30, 2025 -0.07
Jan 31, 2025 -0.11
Oct 31, 2024 -0.25
Jul 31, 2024 -0.31
Apr 30, 2024 -0.35
Jan 31, 2024 -0.55
Oct 31, 2023 -0.58
Jul 31, 2023 -0.68
Apr 30, 2023 -0.70
Jan 31, 2023 -0.72
Oct 31, 2022 -0.76
Jul 31, 2022 -0.89
Apr 30, 2022 -0.99
Jan 31, 2022 -0.93
Oct 31, 2021 -0.71
Jul 31, 2021 -0.48
Apr 30, 2021 -0.24
Jan 31, 2021 -0.18
Oct 31, 2020 -0.17
Jul 31, 2020 -0.17
Jan 31, 2020 -0.18